Clinical Trial Update: Tolerance by Engaging Antigen During Cellular Homeostasis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update from NIAID evaluating a tolerance-inducing approach called 'Tolerance by Engaging Antigen During Cellular Homeostasis' in kidney t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Renal Transplantation

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Kidney Transplantation, Renal Transplantation | Phase 1 | Status: COMPLETED